Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02040675 · ClinicalTrials.gov registry record

Use of NAVA-catheter Positioning Screen to Identify Different Cardiac Arrhythmias

A clinical trial of Cardiac Arrhythmia, sponsored by ProMedica Health System.

Completed
Registry status
5
Enrollment target
1
Study location

NCT02040675 is a study of Cardiac Arrhythmia that has completed, run by ProMedica Health System. The registered enrollment target is 5 participants, below the 213-participant average among 12 other Cardiac Arrhythmia trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02040675, a study of Cardiac Arrhythmia, has completed, sponsored by ProMedica Health System.

COMPLETED
Registry status
5 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to validate a novel method of diagnosing arrhythmias using the NAVA catheter-positioning screen in patients who have a NAVA catheter in place.

Conditions Studied

Study Locations (1)

Ohio

  • Promedica Toledo Hospital - Toledo

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2014-02
Est. Completion 2016-03

Sponsor

ProMedica Health System

12 total trials

What the Registry Record Tells You About NCT02040675

The ClinicalTrials.gov registry entry for NCT02040675 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 213-participant average among 12 other Cardiac Arrhythmia trials with a reported enrollment target (98% lower). The listed sponsor is ProMedica Health System, which has 12 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cardiac Arrhythmia appearing as the primary indexed condition, and to 0 interventions.

NCT02040675 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT02040675 about?

NCT02040675 is a clinical study titled "Use of NAVA-catheter Positioning Screen to Identify Different Cardiac Arrhythmias". The purpose of this study is to validate a novel method of diagnosing arrhythmias using the NAVA catheter-positioning screen in patients who have a NAVA catheter in place.

What is the current status of trial NCT02040675?

This trial is currently completed. The enrollment target is 5 participants. The study started on 2014-02. Estimated completion is 2016-03.

What conditions does trial NCT02040675 study?

This clinical trial studies the following conditions: Cardiac Arrhythmia.

Who is sponsoring clinical trial NCT02040675?

This trial is sponsored by ProMedica Health System, which has 12 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02040675 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiac Arrhythmia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.